Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 17, 2008
Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitisClaudia Pinto Marques Souza de Oliveira, José Tadeu Stefano, Erika Rabelo Forte de Siqueira, et al.
Archives of Endocrinology and Metabolism|December 4, 2023
Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso)Rodrigo Oliveira Moreira, Cynthia Melissa Valerio, Cristiane Alves Villela-Nogueira, et al.
Global Pediatric Health|February 12, 2024
Atypical Hemolytic Uremic Syndrome: A Nationwide Colombian Pediatric SeriesZilac Espitaleta, Alex Domínguez-Vargas, Johanna Villamizar-Martínez, et al.
Clinics (Sao Paulo, Brazil)|October 15, 2025
The impact of the PNPLA3 rs738406 C>G polymorphism on hepatocellular carcinoma risk in Brazilian patients with chronic hepatitis C and advanced fibrosisClaudia Maccali, Isabel Veloso Alves Pereira, Lisa Rodrigues da Cunha Saud, et al.
Annals of Hepatology|October 8, 2020
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver diseaseJuan Pablo Arab, Melisa Dirchwolf, Mário Reis Álvares-da-Silva, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine CountriesZobair M Younossi, James M Paik, Jeffrey V Lazarus, et al.
Gastroenterology|April 13, 2025
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and SteatohepatitisZobair M Younossi, Shira Zelber-Sagi, Jeffrey V Lazarus, et al.
Pageof 5